ArticleJTCVS structural and endovascular2026
Balloon tamponade for central venous catheter-related perforations: A minimally invasive, vessel-sparing case series.
Article in JTCVS structural and endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Iatrogenic central venous injuries are rare but potentially catastrophic complications of catheter-based interventions. Management options remain limited, with surgical repair often infeasible in high-risk patients and covered stents associated with infection risk and permanent loss of access. Although balloon tamponade has been reported anecdotally in peripheral and arterial injuries, its role in central venous catheter-related perforations has not been systematically studied. This case series addresses this gap by evaluating balloon tamponade as a minimally invasive, vessel-preserving strategy for central venous injuries. Methods: We retrospectively reviewed 7 consecutive cases of superior vena cava, brachiocephalic vein, or common iliac vein perforations managed with fluoroscopy-guided balloon tamponade (2021-2025). Procedural details, immediate hemostasis, complications, and long-term outcomes were assessed over 6 to 12 months of follow-up. Results: Balloon tamponade achieved complete hemostasis in 6 of 7 patients, avoiding surgical intervention and preserving vascular access. One case was managed conservatively without balloon inflation. No re-bleeding or long-term complications occurred during follow-up. All patients maintained stable vascular access and experienced full clinical recovery. Conclusions: This case series represents one of the first structured evaluations of balloon tamponade for central venous catheter-related perforations, demonstrating its feasibility, safety, and durable outcomes. By providing vessel-sparing hemostasis without the need for surgical or stent-based intervention, balloon tamponade offers a promising minimally invasive strategy for high-risk patients. These findings highlight its potential role in future management algorithms and underscore the need for prospective studies to standardize the technique and validate its broader application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.